Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-15-082846

Chief Scientific Officer sold 5,500 shares at $65.99 ($362,945)

  • Chief Scientific Officer acquired 5,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Biller Scott · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2015-11-30 Exercise or conversion : show line 1 in the form +5,500 $31.64 $174,020 39,570 D
2015-11-30 Sale : show line 2 in the form −5,500 $65.99 $362,945 34,070 D
Open-market sales · 5,500 sh · avg $65.99 · $362,945

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2015-11-30 Exercise or conversion : show line 3 in the form Stock option (right to buy) −5,500 $31.64 2024-03-04 5,500 279,880 D
Loading xslF345X03/doc4.xml…